(taken from the application) Glucose enters the heart via glucose transporters GLUT1 and GLUT4. GLUT1 mediates basal glucose uptake and GLUT4 translocation is responsible for the acute increase in cardiac glucose uptake in response to: insulin and catecholamine stimulation, hypoxia, ischemia and increased workload. GLUT4 expression in the heart is reduced in diabetes and in cardiac hypertrophy. The reduction in GLUT4 may increase the susceptibility of the heart to ischemic injury. Recent studies in mice with heart selective ablation of GLUT4 confirm the important role of GLUT4 in protecting the heart against ischemic injury. The current proposal seeks to address the question as to whether or not upregulation of cardiac GLUT4 expression will protect the heart from ischemic injury. Two models with upregulation of GLUT4 in the heart have been developed, namely: Mice with cardiac specific deletion of the insulin receptor, and mice treated with low dose isoproterenol. Studies proposed will determine: (1) If these hearts exhibit increased insulin or catecholamine induced glucose uptake in vivo, (2) If these hearts exhibit altered in vivo cardiac physiology (3) If these hearts exhibit diminished susceptibility to ischemic injury (4) The signal transduction pathways which are responsible for the upregulation of cardiac GLUT4 expression. If a positive benefit of increased cardiac GLUT4 expression can be demonstrated and the signal transduction pathways which mediate GLUT4 upregulation are elucidated, these findings will lead to the development of novel therapeutic strategies to treat various cardiac disorders such as hypertrophy, heart failure, ischemic heart disease and diabetic cardiomyopathy.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Research Grants (R03)
Project #
5R03DK058073-03
Application #
6500054
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Hyde, James F
Project Start
2000-09-01
Project End
2003-08-31
Budget Start
2001-09-01
Budget End
2003-08-31
Support Year
3
Fiscal Year
2001
Total Cost
$83,500
Indirect Cost
Name
University of Utah
Department
Genetics
Type
Schools of Medicine
DUNS #
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Graveleau, Christophe; Zaha, Vlad G; Mohajer, Arash et al. (2005) Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action. J Biol Chem 280:31679-85
McQueen, Alfred P; Zhang, Dongfang; Hu, Ping et al. (2005) Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density. J Mol Cell Cardiol 39:882-92
Abel, E Dale (2004) Glucose transport in the heart. Front Biosci 9:201-15
Shimoni, Yakhin; Chuang, Mariette; Abel, E Dale et al. (2004) Gender-dependent attenuation of cardiac potassium currents in type 2 diabetic db/db mice. J Physiol 555:345-54
Hu, Ping; Zhang, Dongfang; Swenson, LeAnne et al. (2003) Minimally invasive aortic banding in mice: effects of altered cardiomyocyte insulin signaling during pressure overload. Am J Physiol Heart Circ Physiol 285:H1261-9
Shiojima, Ichiro; Yefremashvili, Mikkael; Luo, Zhengyu et al. (2002) Akt signaling mediates postnatal heart growth in response to insulin and nutritional status. J Biol Chem 277:37670-7